Literature DB >> 1683235

Association of rheumatoid arthritis with a dominant DR1/Dw4/Dw14 sequence motif, but not with T cell receptor beta chain gene alleles or haplotypes.

J Wallin1, J Hillert, O Olerup, B Carlsson, H Ström.   

Abstract

HLA-DR, HLA-DQ, and T cell receptor beta (TCR beta) chain gene polymorphisms were investigated in 43 patients with rheumatoid arthritis (RA), in 10 patients with Felty's syndrome (FS), and in 5 RA multicase families. RA was found to be strongly associated with a DRB1 gene sequence motif present in DR1, DR4-Dw4, and DR4-Dw14 alleles. Ninety-three percent of RA patients were positive for at least 1 of these alleles, providing strong support for the "shared epitope hypothesis." The frequency distribution of this sequence motif suggests a dominant mode of inheritance. All 10 FS patients were DR4-Dw4 positive. Different DR-DQ associations among DR4 positive RA and FS patients indicate heterogeneity in the genetic susceptibility to these 2 disease entities. Furthermore, analyses of TCR V beta 8, V beta 11, and C beta gene polymorphisms did not support the notion of an influence of TCR beta germline allotypes on RA susceptibility.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1683235     DOI: 10.1002/art.1780341112

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  13 in total

1.  Therapy: Gut-mediated autoimmune arthritis treated with antibiotics.

Authors:  Alan Ebringer
Journal:  Nat Rev Rheumatol       Date:  2010-11       Impact factor: 20.543

2.  Lack of association of T cell receptor V beta 8 polymorphism with rheumatoid arthritis in United Kingdom and Italian white patients.

Authors:  C Lunardi; M Ibberson; S Zeminian; G De Sandre; A K So
Journal:  Ann Rheum Dis       Date:  1994-05       Impact factor: 19.103

3.  HLA-linked rheumatoid arthritis.

Authors:  S J Hasstedt; D O Clegg; L Ingles; R H Ward
Journal:  Am J Hum Genet       Date:  1994-10       Impact factor: 11.025

Review 4.  Prognostic markers in rheumatoid arthritis and classification of antirheumatic therapies.

Authors:  E H Choy; D L Scott
Journal:  Drugs       Date:  1995       Impact factor: 9.546

5.  Greek rheumatoid arthritis patients have elevated levels of antibodies against antigens from Proteus mirabilis.

Authors:  Georgios Christopoulos; V Christopoulou; J G Routsias; A Babionitakis; C Antoniadis; G Vaiopoulos
Journal:  Clin Rheumatol       Date:  2016-10-08       Impact factor: 2.980

Review 6.  T cell genetics and rheumatoid arthritis (RA)

Authors:  P Wordsworth
Journal:  Clin Exp Immunol       Date:  1998-03       Impact factor: 4.330

7.  Genetic epidemiology of rheumatoid arthritis.

Authors:  A H Lynn; C K Kwoh; C M Venglish; C E Aston; A Chakravarti
Journal:  Am J Hum Genet       Date:  1995-07       Impact factor: 11.025

8.  HLA class II and T-cell receptor beta chain polymorphisms in Belgian patients with rheumatoid arthritis: no evidence for disease association with the TCRBC2, TCRBV8 and TCRBV11 polymorphisms.

Authors:  C Vandevyver; X X Gu; P Geusens; M Spaepen; L Philippaerts; J J Cassiman; J Raus
Journal:  Ann Rheum Dis       Date:  1994-09       Impact factor: 19.103

Review 9.  T-cell antigen receptors in rheumatoid arthritis.

Authors:  L I Sakkas; P F Chen; C D Platsoucas
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

10.  Antibacterial and antipeptide antibodies in Japanese and Finnish patients with rheumatoid arthritis.

Authors:  T Rashid; M Leirisalo-Repo; Y Tani; S Hukuda; S Kobayashi; C Wilson; S Bansal; A Ebringer
Journal:  Clin Rheumatol       Date:  2004-02-13       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.